These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 13043377
1. Clinical and oscillographic studies on the activity of a new watersoluble theophylline derivative, DHT. HILLER E. Dtsch Med Wochenschr; 1953 Jan 02; 78(1):17-9. PubMed ID: 13043377 [No Abstract] [Full Text] [Related]
2. [Clinicotherapeutic research on a new synthetic theophylline derivative]. ASCIONE A, VITALE P. Minerva Med; 1956 Oct 24; 47(85):1347-51. PubMed ID: 13387273 [No Abstract] [Full Text] [Related]
3. [Therapy of cardiovascular disorders and hypertension with a new purine derivative]. SACHSSE B. Dtsch Med Wochenschr; 1953 Nov 06; 78(45):1563-4. PubMed ID: 13107392 [No Abstract] [Full Text] [Related]
4. [Clinical experiences with soluble theophylline derivatives]. BROGLIA F. Minerva Med; 1959 Oct 06; 50():3158-64. PubMed ID: 13804692 [No Abstract] [Full Text] [Related]
6. [Experiences in the clinical application of oxyethyltheophylline (cordalin)]. BAMMELUND E, KAISER R. Med Klin; 1953 Nov 20; 48(47):1741-4. PubMed ID: 13110707 [No Abstract] [Full Text] [Related]
7. The use of buthoids (butaphyllamine suppositories) as adjuncts in the treatment of cardiovascular disease. OSBORN DP. Ohio State Med J; 1953 Oct 20; 49(10):885-7. PubMed ID: 13099804 [No Abstract] [Full Text] [Related]
8. [Results with bilophyllin]. BERGER F. Prakt Arzt; 1952 Jan 15; 6(56):46-9. PubMed ID: 12993634 [No Abstract] [Full Text] [Related]
9. [Clinical experiences with the new vasodilator permanil]. LAMPRECHT G. Munch Med Wochenschr; 1957 Jul 12; 99(28):1028-9. PubMed ID: 13464779 [No Abstract] [Full Text] [Related]
10. [Adenosine in cardiovascular disorders]. LANDEN HC. Medizinische; 1959 May 16; 4(20):986-8. PubMed ID: 13673834 [No Abstract] [Full Text] [Related]
11. [Therapeutic activity of choline theophyllinate associated with papaverine trichlorohydroxyethyl-p-aminobenzoate]. CAVALLINI L. Minerva Med; 1958 Mar 07; 49(19):805-9. PubMed ID: 13541079 [No Abstract] [Full Text] [Related]
14. [New and authenticated theories from the area of theophylline and strophanthin therapy]. THURAU H. Med Klin; 1959 Mar 06; 54(10):419-21. PubMed ID: 13643600 [No Abstract] [Full Text] [Related]
15. [The clinical use of the water soluble theophylline preparation DHT (dihydroxypropyl-theophyllin)]. GENSLER W, GADERMANN E. Ther Ggw; 1953 Jan 06; 92(1):12-6. PubMed ID: 13077449 [No Abstract] [Full Text] [Related]
16. [Surgical experiences with DHT (Dihydroxy-propyl-theophyllin)]. STAEHLER W, HENFTLING T. Medizinische; 1952 Jun 21; 31(25):865-7. PubMed ID: 12982406 [No Abstract] [Full Text] [Related]
17. [Effect of theophylline preparation on blood circulation]. THIESS A. Med Klin; 1953 Oct 09; 48(41):1528-9. PubMed ID: 13098833 [No Abstract] [Full Text] [Related]
18. [Dioxypropyl theophylline (thefylan, Pharmacia); clinical trial of a new, water-soluble and non-irritative theophylline derivative]. SJOBERG SG, BRANTE G, BRUN O. Sven Lakartidn; 1953 Jun 19; 50(25):1349-63. PubMed ID: 13090112 [No Abstract] [Full Text] [Related]
19. [The biological and symptomatic effects of a new synthetic theophylline derivative on chronic peripheral arterial diseases]. ASCIONE A, CONTI A, NIGRO G. Minerva Cardioangiol Eur; 1958 Jun 19; 4(1):125-7. PubMed ID: 13552045 [No Abstract] [Full Text] [Related]
20. [Clinical experience with a new theophylline derivative, hydroxyethyltheophylline]. LURMANN OW, BORES W. Dtsch Med Wochenschr; 1952 Jan 04; 77(1):15-7. PubMed ID: 14916621 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]